Concurrent EGFR amplification and TP-53 mutation in glioblastomas

Clinical Neuropathology

Volumn 26, Issue 5, 2007, Pages 224-231

  Gil Benso, R ^a   Lopez Gines, C ^a   Benito, R ^a   Lopez Guerrero J A ^b   Callaghan, R C ^a   Pellin A ^a   Roldan P ^c   Cerda Nicolas M ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

9p21 locus; Cytogenetics; Epidermal growth factor receptor gene; Glioblastoma; TP 53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN SCINTISCANNING; CANCER GRADING; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METHYLATION; PRIORITY JOURNAL;

EID: 34548650079     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/npp26224     Document Type: Article

References (21)

1. Bansal K, Liang ML, Rutka JT. Molecular biology of human gliomas. Technol Cancer Res Treat. 2006; 5: 185-193.
2. Grossman SA, Batara JF. Current management of glioblastoma multiforme. Semin Oncol. 2004; 31: 635-644.
3. Hamroun D, Kato S, Ishioka C, Claustres M, Beroud C, Soussi T. The UND TP53 database and website: update and revisions. Hum Mutat. 2006; 27: 14-20.
4. Hassler M, Seidl S, Fazeny-Doerner B, Preusser M, Hainfellner J, Rossler K, Prayer D, Marosi C. Diversity of cytogenetic and pathohistologic profiles in glioblastoma. Cancer Genet Cytogenet. 2006; 166: 46-55.
5. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996; 93: 9821-9826.
6. ISCN. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger; 1995. pp. 30-76.
7. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Nordenskjold M, Larsson C. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet. 1993; 92: 169-174.
8. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neurooncol. 1999; 1: 44-51.
9. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002; 61: 215-225.
10. Korshunov A, Sycheva R, Golanov A. Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH). Acta Neuropathol. 2006; 111: 465-474.
11. Maher EA, Brennan C, Wen PY, Durso L, Ligon KL, Richardson A, Khatry D, Feng B, Sinsha R, Louis DN, Quackenbush J, Black PM, Chin L, DePinho RA. Marked genomic differences characterize Primary and Secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. Cancer Res. 2006; 66: 11502-11513.
12. Meyer-Puttlitz B, Hayashi Y, Waha A, Rollbrocker B, Bostrom J, Wiestler OD, Louis DN, Reifenberger G, von Deimling A. Molecular-genetic analysis of giant cell glioblastomas. Am J Pathol. 1997; 151: 853-857.
13. Mitelman F, Johansson B, Mertens F. Database of chromosome aberration in cancer. http://cgap.nci.nih; 2006.
14. Nakamura M, Watanabe T, Klangby U, Asker C, Wiman K, Yonekawa Y, Kleihues P, Ohgaki H. p14ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol. 2001; 11: 159-168.
15. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004; 64: 6892-6899.
16. Ohgaki H. Genetic pathways to glioblastomas. Neuropathology 2005; 25: 1-7.
17. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005; 64: 479-489.
18. Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10: 2243-2246.
19. Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK, Dobra A, Dressman HK, Bigner DD, Nevins JR, West M. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res. 2005; 65: 4051-4058.
20. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 1996; 6: 217-223.
21. Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch M. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA methyltransferase. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1774-1783.